Neuroendocrine Tumors: An Evidence-Based Discussion

EP. 1: Clinical and Biological Distinctions in Neuroendocrine Tumors

February 16th 2016

EP. 2: Disease Factors Influencing Initial Treatment Approaches in NETs

February 16th 2016

EP. 3: Determining Surgical Candidacy in NETs

February 16th 2016

EP. 4: Symptom Management in Functional NETs

February 16th 2016

EP. 5: Goals of Therapy with Somatostatin Analogs in NETs

February 16th 2016

EP. 6: The Role of Surgery in the Management of NETs

February 16th 2016

EP. 7: Anti-Angiogenesis and mTOR Inhibition in Carcinoid Tumors

February 16th 2016

EP. 8: Chemotherapy Options in Neuroendocrine Tumors

February 16th 2016

EP. 9: Peptide Receptor Radionuclide Therapy in NETs

February 16th 2016

EP. 10: Sequencing Decisions in Neuroendocrine Tumors

February 16th 2016

EP. 11: Management of Obstruction-Related Symptoms for NETs

February 16th 2016

EP. 12: Systemic Treatment Options and Sequencing in pNETs

February 16th 2016

EP. 13: The Potential for Combination Therapy in Neuroendocrine Tumors

February 16th 2016